Pancreas-specific activation of mTOR and loss of p53 induce tumors reminiscent of acinar cell carcinoma
Pancreatic acinar cell carcinoma (ACC) is a rare tumor entity with an unfavorable prognosis. Recent whole-exome sequencing identified p53 mutations in a subset of human ACC. Activation of the mammalian target of rapamycin (mTOR) pathway is associated with various pancreatic neoplasms. We thus aimed...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
18 December 2015
|
| In: |
Molecular cancer
Year: 2015, Volume: 14, Issue: 1 |
| ISSN: | 1476-4598 |
| DOI: | 10.1186/s12943-015-0483-1 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12943-015-0483-1 Verlag, lizenzpflichtig, Volltext: https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-015-0483-1 |
| Author Notes: | Bo Kong, Tao Cheng, Chengjia Qian, Weiwei Wu, Katja Steiger, Jing Cao, Anna Melissa Schlitter, Ivonne Regel, Susanne Raulefs, Helmut Friess, Mert Erkan, Irene Esposito, Jörg Kleeff and Christoph W. Michalski |
| Summary: | Pancreatic acinar cell carcinoma (ACC) is a rare tumor entity with an unfavorable prognosis. Recent whole-exome sequencing identified p53 mutations in a subset of human ACC. Activation of the mammalian target of rapamycin (mTOR) pathway is associated with various pancreatic neoplasms. We thus aimed at analyzing whether activation of mTOR with a concomitant loss of p53 may initiate ACC. |
|---|---|
| Item Description: | Gesehen am 15.07.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1476-4598 |
| DOI: | 10.1186/s12943-015-0483-1 |